Abstract. Barrett's esophagus (BE) is a type of precancerosis and a key risk factor for esophagus adenocarcinoma (EAC). Tumor stem cells may be the source for BE transforming to EAC. Octamer transcription factor-3/4 (OCT3/4) and SOX2 are the main transcriptional controlling factors and markers of tumor stem cells. In the present study, we observed that the expressions of OCT3/4, SOX2, TCL1 and AKT1 in BE were elevated compared to normal esophagus but were decreased compared to EAC. Moreover, we isolated a few stem-like cells in OE33 cells which showed similar biological behavior to tumor stem cells. Notably, we found that downregulation of OCT3/4 expression by siRNA inhibited the ability of clone formation and invasion of OE33 cells, and decreased the formation of side population cells and slow cycle cells. Therefore, we concluded that OCT3/4 and SOX2 play a critical role in the transformation of BE to EAC by regulating the formation of tumor stem cells and the TCL1/AKT1 pathway.
Introduction
Barrett's esophagus (BE) is the physical phenomenon that the stratified squamous epithelia of the lower esophagus are substituted by metaplastic simple columnar epithelia. BE is a type of precancerosis of esophagus adenocarcinoma (EAC). The incidence of EAC has markedly increased, especially in Western industrialized countries (1) . For BE patients, the risk of developing EAC has increased 30-125-fold compared to individuals not suffering from BE. Therefore, BE is considered the key risk factor for EAC (2) . However, the factors that play a critical role in the transformation of BE to EAC remain unclear. In recent years, tumor stem cells have been regarded as the source of tumor growth, metastasis and recurrence due to their potential of self-renewal and differentiation. Tumor stem cells are known to exist in different tumors from several types of tissues and organs. Tumor cells, especially poorly differentiated tumor cells exhibit similar phenotypes and biological characteristics as stem cells. For example, they both have the ability of self-renewal and differentiation (3, 4) . Therefore, it may be assumed that tumor stem cells are the source of the transformation of BE to EAC. Octamer transcription factor-3 (OCT3) and SOX2 are the transcription factors necessary to maintain cell totipotency; they play critical roles in the regulation of embryo development and are involved in self-renewal of embryonic stem cells or primordial germ cells. OCT3 and SOX2 combine to form an OCT3/SOX2 complex, bind to target genes in a sequence-specific manner and play a vital role in the signal regulation network of stem cells (5, 6) . Our previous studies demonstrated that according to gene chip analysis, the expression of OCT3, SOX2 and their downstream candidate gene TCL1/AKT1 were upregulated in BE tissue (7) . Therefore, we assumed that during the progression of the transformation of BE to EAC, OCT3 and SOX2 in the metaplastic simple columnar epithelium were activated and combined to form the OCT3/SOX2 complex, they switched on the TCL1/AKT1 signal pathway, and then promoted the transformation of epithelium cells to stem cells with the ability of continued proliferation and differentiation. In the present study, firstly, the expressions of OCT3, SOX2, TCL1 and AKT1 in BE and EAC tissue, respectively, was observed, and then the stem-like cells (SP and slow cycle cells) were isolated from EAC cell lines (OE33) and their biological characteristics were observed. Furthermore, the present study demonstrated the impact of OCT3 siRNA on the expression of SOX2, TCL1 and AKT1, and described the biological characteristics of stem-like cells. The membranes were then incubated in 5% skim milk at room temperature for 2 h, followed by addition of the first antibody (1:1,000) and incubation at 4˚C overnight. The following day, the membranes were washed three times with phosphate-buffered saline (PBS), followed by incubation with the secondary antibody at room temperature for 2 h. The protein bands were finally visualized on X-ray film using ECL. The images were subjected to grayscale analysis using BandScan software.
Materials and methods

Clinical
Primer pairs and hydrolysis probe for real-time PCR. The primers and hydrolysis probes for OCT3, COT4, SOX2 and GAPDH were designed by Universal Probe Library Assay Design Center (Roche, Mannheim, Germany) ( Table I ). The primers were synthesized by TIB MolBiol (USA) and the hydrolysis probe was purchased from Roche.
RNA isolation, RT-PCR and real-time RT-PCR analysis.
RNA was extracted from tissue samples using the High Pure RNA Tissue kit (Roche) and from cell lines using the RNeasy Mini kit (Qiagen, Hilden, Germany) according to the manufacturer's recommendations. The cDNA preparation from total RNA was performed with 500 ng RNA (20 µl total volume) using the Script cDNA Synthesis kit (Bio-Rad, Munich, Germany). Quantitative analysis of target gene transcripts was performed by real-time RT-PCR using the QuantiTect SYBR-Green PCR kit (Qiagen). For the amplification, an initial denaturation at 95˚C for 15 min, followed by 15 sec at 94˚C, 30 sec at 55˚C and 30 sec at 72˚C for 35 cycles was used. Samples were run on a LightCycler ® 480 Real-Time PCR system (Roche). The relative expressions were calculated by normalization to GAPDH gene expression.
Isolation of side population (SP) and main population (MP)
cells from the OE33 cell line using Hoechst 33342 dye. The cells were suspended in pre-warmed RPMI-1640 containing 2% FBS and 2 mM HEPES (HBSS) at 1x10 6 cells/ml at 37˚C for 10 min, and incubated at 37˚C for an additional 90 min in a shaking bath with 5 µg/ml (8.1 µM) Hoechst 33342 dye. Control cells were incubated with 50 µM verapamil (Sigma, St. Louis, MO, USA) for 15 min at 37˚C before Hoechst dye addition. After centrifugation at 1,300 rpm at 4˚C for 5 min, cells were washed and resuspended in cold HBSS containing 20 µg/l PI and then placed immediately on ice. The SP/MP cells were gated separately and analyzed using an LSR II flow cytometer (BD Biosciences, San Jose, CA, USA). The blue light signal was collected by a 450/20 band pass filter, and the red light signal was collected by a 675 nm pass filter. PI-positive dead cells were removed. Among the PI-negative cells, Hoechst 33342-negative or weakly-positive cells were considered the SP subgroup, and Hoechst 33342-positive cells were considered the MP group.
Isolation of slow cycle cells and rapid cycle cells from the OE33 cell line by Dil dye.
Cells were incubated at 37˚C for 5 min with 5 µl/ml Dil dye. Then, the cells were washed three times with RPMI-1640 to remove the Dil dye. After culturing for 5-6 weeks, only very few cells were illuminated under the inverted fluorescence microscope. Next, the cells were isolated using the LSR II flow cytometer and the red light signal was collected by an 585/40 nm filter. Slow cycle cells were Dil-positive and rapid cycle cells were Dil-negative.
Colony forming efficiency assay. The isolated cells were plated at 300 cells/well in a six-well tissue culture plate and grown for 14 days until macroscopic cell clones were demonstrated. The cells were then fixed with 95% cold methanol for 15 min at 4˚C and stained with 0.5% methylene blue solution for 2 min in order to count the number of colonies by microscopy. Colony forming efficiency was calculated as the percentage of single cells that generated colonies at day 14. Cell clone formation rate = (number of clones/300) x 100%.
In vitro invasion assay. In the Transwell chamber assay (Chemicon, USA), 50 µl cell suspension (1x10 5 cells/ml) was added into the chamber's upper insert. After 24 h in cell culture, the internal cell layer was scraped from the chamber, fixated with 10% formalin, Giemsa stained and membranepenetrating cells were counted.
siRNA construction and cell transfection. Three OCT3, SOX2 siRNA sequences purchased from Qiagen (USA) were sequenced and blast compared. The results confirmed consistency with human OCT3 and SOX2 cDNAs as registered in GenBank. These sequences were mixed with Oligofectamine (Invitrogen, USA) to obtain a concentration of 100 nM, and then transfected into OE33 cells (1x10 5 cells/ml). At the same time, the blank control group (ConB), void vector group (ConA) and negative transfection group (ConN) were placed. PBS was added to the ConB group. Void vectors of the same concentration were added to the ConA group. Negative sequences to the target genes were added to the ConN group.
Statistical analysis. Data are summarized as means ± SD from three or more independent experiments. Statistical analysis was performed by using two-tailed Student's t-test for paired data. p<0.05 was considered to indicate a statistically significant difference.
Results
The expressions of OCT3, SOX2, TCL1 and AKT1 increase in BE tissue compared to normal esophagus tissue, respectively, but decrease compared to EAC tissue. Immunohistochemical detection showed positive staining of OCT3, SOX2, TCL1 and AKT1 proteins, demonstrated by yellow or brown color and mainly located in cell nuclei (Fig. 1) . Only traces of the expression of the proteins mentioned above were detected in normal esophagus tissue, but expression was elevated in BE tissue and EAC tissue. Analysis of areas of positive expression using the Image-Pro Plus system indicated that the absorbance values, and total absorbance values of the four proteins mentioned above were increased in BE tissue compared to normal tissue (p<0.01) but decreased compared to EAC tissue (p<0.05), respectively (Table II) . (Fig. 2) .
The ability of clone formation and the invasion of SP cells and slow cycle cells are strengthened. The plate clone formation test showed the number of clones formed by SP cells was 186±24, and the rate of clone formation was 58.65±6.32%. The number of clones formed by MP cells was 68±18, and the rate of clone formation was 22.6±2.44%. There was a statistically significant difference between SP and MP cells (t=3.486, p<0.01). The number of clones formed by slow cycle cells (192±46) and the rate of clone formation (61.82±7.63%) were statistically significantly higher compared to the quick cycle cells (58±11, 17.2±1.2%) (t=5.326, p<0.01) (Fig. 3A) Table II . The expression of OCT3, SOX2, TCL1 and AKT1 detected by immunohistochemistry (mean ± SD). -------------------------------------------------------------------------------------------- - increased compared to quick cycle cells (1.86±1.12%) (t=5.462, p<0.01) (Fig. 3B) . (Fig. 4A) . mRNA levels were determined by real-time RT-PCR and the results showed that mRNA levels of OCT3, SOX2, TCL1, AKT1 in SP/slow cycle cells were statistically significantly elevated compared to MP/quick cycle cells (p<0.05) (Fig. 4B) .
OCT3/4 SOX2 ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------
OCT3-siRNA downregulates the expression of SOX2, TCL1
and AKT1. After transfection of OE33 SP cells or slow cycle cells with OCT3-siRNA, the expression of OCT3 was statistically significantly decreased compared to control groups, including ConA, ConB or ConN (p<0.01). Furthermore, downregulation of OCT3 expression by siRNA reduced the expression of SOX2, TCL1 and AKT1 protein or mRNA statistically significantly compared to control groups (p<0.01) (Fig. 5) . (Fig. 6) .
OE33 cell transfection with OCT3-siRNA reduces the number of SP cells and slow cycle cells.
In order to explore the effects of OCT3-siRNA on tumor stem-like cells in OE33 cells, OE33 cells were transfected with siRNA. After inhibition of OCT3, Hoechst 33342 dyeing showed statistically significantly fewer SP cells being isolated compared to the control with no addition of OCT3-siRNA (0.34±0.08 vs. 1.2±0.56%, p<0.05). Moreover, statistically significantly fewer slow cycle cells were detected by Dil dyeing (0.36±0.06 vs. 1.4±0.68%, p<0.05) (Fig. 7) .
Discussion
As a member of the POU transcription factor family, OCT3 is involved in the self-renewal of embryonic stem cells and primordial germ cells and is considered a marker for the pluripotency of stem cells (9) . The expression of OCT3 in differentiated or mature tissue is very low, or even non-existent (10,11) . SOX2, as a member of the SOX (SRY-related HMG box) family (12) plays a critical role in the regulation of the development of embryonic stem cells, maintaining pluripotency of stem cells and deciding cell fate (13, 14) . OCT3 and SOX2 combine together forming a complex (OCT3/SOX2). OCT3 and SOX2 are not only expressed in embryonic stem cells and germ cells but also in some tumor cells as, for example, in breast cancer (15, 16) , germinoma (17, 18) , pancreatic (19, 20) , liver (21), bladder (22) , lung cancer (23) and renal medullary carcinoma (24) . Furthermore, OCT3 expression is observed in human breast stem cells, pancreatic stem cells, liver stem cells. It is believed that OCT3-positive tumor cells may be derived from OCT3-positive somatic stem cells (21) . The expression of OCT3 in BE tissue was found to be elevated compared to normal esophagus tissue, but decreased compared to EAC tissue. We hypothesized that there were a few stem-like cells in BE tissue that were stimulated by some risk factors and then transformed into EAC.
The TCL1 oncogene located at 14q32.1 is involved in the development of human mature T-cell leukemia. It was found as one of the downstream candidate genes of OCT3 and played an important role in early mouse embryos and ES cells (25) . It has been shown that TCL1 enhances the kinase activity of AKT1 (26) . AKT1 is one of the key kinases enhancing cell proliferation and inhibiting apoptosis. It has also been shown that the activation of AKT1 is sufficient to maintain the undifferentiated state of mouse ES cells (27) and that the OCT3-TCL1-AKT1 pathway plays an important role in early mouse embryos and ES cells (28) . In the present study, we also measured the expression of TCL1 and AKT1 in BE or EAC tissue. Notably, we found that TAL1 or AKT1 were also elevated in BE or EAC tissue compared to normal esophagus tissue. Based on this observation, we hypothesized that the OCT3/SOX2-TCL1-AKT1 pathway plays an important role in the transformation of BE to EAC.
To date, tumor stem cells have been isolated from several different types of cancer, including leukemia (29,30), brain neoplasms (31, 32) , breast (33) , prostate cancer (34), hepatocellular carcinoma (35) , colon cancer (36), head and neck squamous cell carcinoma (37) . We isolated SP and slow cycle cells having stem cell characteristics using Hoechst 33342 and Dil dye, respectively. Hoechst 33342 is a nuclei fluorescent dye which is pumped by stem cells. Therefore, the stem cells may not be dyed by Hoechst 33342 but are inhibited by a blocking agent (verapamil). Due to this property, SP cells may be isolated using flow cytometry (38, 39) . SP cells were isolated from neuroblastoma, breast, lung cancer, spongioblastoma (40) and ovarian cancer cell lines (41) . SP cells have the same characteristics as stem cells including self-renewal and multi-direction differentiation. The clone formation test was an effective method to detect proliferation of single cells, and the Transwell test was used to check cell metastasis. In the present study, ~1.2% of cells isolated were SP cells and the ability of clone formation and metastasis of SP cells were increased compared to MP cells.
Another way to separate stem cells involves the mark detaining test which is based on the long cell cycle of stem cells (42) . Since stem cells are normally in stationary phase, the marker is detained after a long time in culture and can be detected. However, the marker is diminished with fast dividing and cannot be detected. The cells detected this way are called slow cycle cells and exhibit the characteristics of stem cells. In the past, bromodeoxyuridine (BrdU) was used. A new cell membrane marker, Dil, has recently found widespread application. DiI is a type of lipophilic membrane marker that sends out fluorescence when integrated in the membrane. Its beneficial properties include a higher labeling efficiency, shorter labeling time and less cytotoxicity (43) . To date, slow cycle cells have been detected in tumors of, for example, intestine (44), breast (45) , skin (46) and cornea (47) . In the present study, ~1.4±0.26% of cells separated from OE33 cells were considered to be slow cycle cells. Slow cycle cells are smaller than quick cycle cells and have a strengthened ability of clone formation and invasion.
In the present study, the regulatory role of downregulation of OCT3 by siRNA was elucidated. RNAi is an effective way to silence post transcriptional genes and is extensively used to inhibit specific gene expression (48, 49) . OE33 cells were transfected with OCT3-siRNA to silence OCT3 expression. Downregulation of OCT3 expression by siRNA inhibited the clone formation and invasion ability of OE33 cells. It has been shown that inhibition of OCT3 reduces tumor malignancy. Recent studies showed that somatic stem cells with high expression levels of OCT3 are the origin of tumorigenesis (21, 50, 51) , and knocking out the OCT4 gene in mice causes embryo death during the prophase of embryo development (52) and causes embryo stem cell differentiation to the endoblast directly (53) . This study demonstrated that the downregulation of OCT3 in OE33 cells decreased the formation of SP and slow cycle cells. Western blotting and real-time PCR detection showed that inhibition of OCT3 reduced the expression of SOX2, TCL1 and AKT1. Therefore, it is our hypothesis that downregulation of OCT3 may inhibit the carcinogenesis of EAC by reducing the activity of SOX2 and blocking the TCL1/AKT1 pathway.
In conclusion, OCT3 and SOX2 are markers of tumor stem cells which are highly expressed in BE tissue compared to normal esophagus tissue but their expression is decreased compared to EAC tissue. There are a few stem-like cells in OE33 cells which exhibit similar biological behavior to tumor stem cells. Downregulation of OCT3 expression by siRNA inhibited the ability of clone formation and invasion of OE33 cells, and decreased the formation of SP and slow cycle cells. OCT3 and SOX2 play a critical role in the transformation of BE to EAC by regulating the formation of tumor stem cells by switching on the TCL1/AKT1 pathway.
